Articles related to CANCER SCREENING

New data suggests that the Galleri blood test’s sensitivity for early-stage cancers may be lower than initially reported, potentially limiting its utility as a screening tool.

The annual cost of cancer screening represents a notable portion of overall U.S. health care system costs related to cancer, with private insurance covering the majority of expenses.

Informed consent in breast cancer screening can lead to different choices: 20% of women in their 40s may choose to delay mammograms when presented with comprehensive risk-benefit information.

Basal cell carcinoma, while common, rarely leads to death when detected and treated early. Physicians should be aware of the seven warning signs that can be mistaken for harmless skin conditions.

Physicians are urged to navigate evolving breast cancer screening guidelines with caution, prioritizing patient-centered care amid shifting evidence landscapes.

This innovative device can transform breast cancer screening by providing a rapid, affordable, and non-invasive diagnostic solution, particularly beneficial in regions with limited access to traditional screening methods.